Dr. Reddy's Expands Portfolio - Analyst Blog
News | 09 August 2012
Dr. Reddy's Laboratories ( RDY ) recently announced the launch of its generic version of Merck & Co 's ( MRK ) blockbuster asthma and allergy drug Singulair (montelukast) following the receipt of US Food & Drug Administration (FDA) approval for its ...
Click on the link to read the full article at NASDAQ
(This link will open in a new window)
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
